OUR PRODUCTS
OUR PRODUCTS
OUR PRODUCTS
Our end-to-end products enable the application of genomics in oncology to improve patient care by integrating molecular and clinical data, streamlining workflows, and providing decision support. All of our products are powered by our KMS and all share a common API suite which makes it easy for all of our products to communicate and effectively integrate with each other and institution-specific applications.
Our end-to-end products enable the application of genomics in oncology to improve patient care by integrating molecular and clinical data, streamlining workflows, and providing decision support. All of our products are powered by our KMS and all share a common API suite which makes it easy for all of our products to communicate and effectively integrate with each other and institution-specific applications.
Our end-to-end products enable the application of genomics in oncology to improve patient care by integrating molecular and clinical data, streamlining workflows, and providing decision support. All of our products are powered by our KMS and all share a common API suite which makes it easy for all of our products to communicate and effectively integrate with each other and institution-specific applications.
We create flexible, knowledge-enabled solutions
We create flexible, knowledge-enabled solutions
We create flexible, knowledge-enabled solutions
OUR
LEADERSHIP TEAM
Our Leadership team is comprised of a mix of innovative, experienced, and scientific-minded leaders who have set the tone for GenomOncology's ambitious and driven culture.
BRAD WERTZ
Chief Executive Officer
Formerly the President and COO of Rosetta, Brad Wertz helped grow the company from $115M to $225M before its sale to Publicis. Before Rosetta, He served as COO for Brulant and also held senior executive positions at several other startups including bioinformatics company Acero.
GINA DROBNICK
Chief Operating Officer
Gina Drobnick has more than 25 years of experience as both a management consultant and an operations executive. Gina also worked at Ernst & Young, Arthur Andersen, Brulant as an Associate Partner in their creative group, and Level Seven, Inc. as their Chief Operating Officer.
JUSTIN YEAKLEY
VP of Product Development
Justin Yeakley supports and supervises all activities related to the design, development, and implementation of GO's suite of products. Justin has over 12 years of software development and leadership experience and was previously Director of Application Development at Rosetta.
IAN MAURER
Chief Technology Officer
Ian Maurer leads the full lifecycle of application design, architecture, development, and quality assurance. Ian has over 17 years of software development and leadership experience working for Lockheed Martin, Ernst & Young, Brulant, and Rosetta.
TERESA FLETCHER, CHP
Senior VP of Business Development
Teresa Fletcher is a seasoned business development professional with a deep understanding of oncology and the healthcare ecosystem. Teresa has over 17 years experience with enterprise solution sales holding positions at various healthcare startups within sales and customer management.
JEFF SMITH
VP of Finance
Jeff Smith has more than 24 years of experience in the areas of accounting, finance, operations, and business development. Prior to GO, Jeff was the Chief Financial Officer for several Private Equity backed lower middle-market companies both domestically and abroad.